Links/Summaries to New Hepatitis C Articles

[Guest guest]

News10 new results for Hepatitis Drug Firms Told to Pay $162 Million in

Hepatitis C Case

Fox News

The civil trials are the first of several now reaching trial phases in Las Vegas

stemming from the 2008 hepatitis outbreak traced to colonoscopy clinics run by

Dr. Dipak Desai. Southern Nevada health officials advised about 50000 patients

who received ...

See all stories on this topic »Pharmasset expands hepatitis C trial; shares rise

Reuters

O) said it will expand a mid-stage trial of its experimental hepatitis C drug

with the further addition of two arms, sending its shares to a life-high.

Pharmasset's PSI-7977, which belongs to a class of compounds called nucleotide

analogues, ...

See all stories on this topic »Hepatitis C Phase 2A Trial Positive Results

MarketWatch (press release)

Australian drug development company Biotron Limited (asx:BIT) has released

headline results from its landmark Phase 2a trial of its lead drug candidate,

BIT225 in Hepatitis C virus (HCV) infected patients. Preliminary analysis of

trial data confirms ...

See all stories on this topic »Gov. Jerry Brown signs bills expanding drug user

access to syringes

Los Angeles Times

Jerry Brown on Monday signed two bills that will expand access to sterile

syringes for drug users in an effort to combat the spread of hepatitis C and

HIV. The first bill, written by Sen. Leland Yee (D-San Francisco), allows people

to buy syringes at ...

See all stories on this topic »271 turn out for hepatitis A vaccines

WFMZ town

A plate of pasta may earn you a Hepatitis shot. So far, 271 customers have

received vaccines after a kitchen worker at Pasta Alla in town

contracted Hepatitis A. The city health bureau will offer shots again on Tuesday

morning. ...

See all stories on this topic »

Engineering Hope: Curing Hepatitis C

KERA

DALLAS, TX (KERA) - The Center for Disease Control estimates that more than

three million Americans are chronically infected with hepatitis C. In Dallas,

University Of Texas Southwestern's Dr. Lee first started seeing patients

more than twenty ...

See all stories on this topic »

KERAPharmasset again expands hepatitis C drug study

Forbes

AP , 10.10.11, 01:28 PM EDT Shares of Pharmasset Inc. jumped Monday after the

company expanded a clinical trial of its experimental hepatitis C drug to

include new hard-to-treat patients. By expanding the trial, the company gave

Wall Street another ...

See all stories on this topic »Scripps Florida scientist to study Hepatitis C

TCPalm

JUPITER — The Scripps Research Institute has been awarded a $2.2 million grant

by the National Institutes of Health (NIH) to determine how the hepatitis C

virus (HCV) induces liver cancer. The research could lead to potentially new

therapeutic targets ...

See all stories on this topic »

Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn

more.